These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7913919)

  • 21. Tolerability of enteric-coated sulphasalazine in rheumatoid arthritis: results of a co-operating clinics study.
    Donovan S; Hawley S; MacCarthy J; Scott DL
    Br J Rheumatol; 1990 Jun; 29(3):201-4. PubMed ID: 1972633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.
    Pullar T; Hunter JA; Capell HA
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1102-4. PubMed ID: 6138117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sulphasalazine in rheumatoid arthritis.
    Boey ML; Lee E; Feng PH
    Singapore Med J; 1988 Jun; 29(3):285-8. PubMed ID: 2903555
    [No Abstract]   [Full Text] [Related]  

  • 24. Lichen planus in patients with rheumatoid arthritis treated with sulfasalazine.
    Kaplan S; McDonald E; Marino C
    J Rheumatol; 1995 Jan; 22(1):191-2. PubMed ID: 7699675
    [No Abstract]   [Full Text] [Related]  

  • 25. Enumeration of IgA producing cells by the enzyme linked immunospot (ELISPOT) technique to evaluate sulphasalazine effects in inflammatory arthritides.
    Feltelius N; Gudmundsson S; Wennersten L; Sjöberg O; Hällgren R; Klareskog L
    Ann Rheum Dis; 1991 Jun; 50(6):369-71. PubMed ID: 1676256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatal neutropenic enterocolitis associated with sulphasalazine therapy for rheumatoid arthritis.
    Chakravarty K; Scott DG; McCann BG
    Br J Rheumatol; 1992 May; 31(5):351-3. PubMed ID: 1349846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sulphasalazine induced hepatitis in juvenile rheumatoid arthritis.
    Caspi D; Fuchs D; Yaron M
    Ann Rheum Dis; 1992 Feb; 51(2):275-6. PubMed ID: 1347987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines.
    Ransford RA; Langman MJ
    Gut; 2002 Oct; 51(4):536-9. PubMed ID: 12235076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate.
    Bax DE; Amos RS
    Ann Rheum Dis; 1985 Mar; 44(3):194-8. PubMed ID: 2858182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutropenia in patients with rheumatoid arthritis, treated with sulphasalazine.
    Marouf ES; Morris IM
    Br J Rheumatol; 1990 Oct; 29(5):407-9. PubMed ID: 1977490
    [No Abstract]   [Full Text] [Related]  

  • 31. Toleration, side-effects and efficacy of sulphasalazine in rheumatoid arthritis patients of different ages.
    Wilkieson CA; Madhok R; Hunter JA; Capell HA
    Q J Med; 1993 Aug; 86(8):501-5. PubMed ID: 8105504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine.
    Nuver-Zwart IH; van Riel PL; van de Putte LB; Gribnau FW
    Ann Rheum Dis; 1989 May; 48(5):389-95. PubMed ID: 2567150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrocytosis and sulphasalazine treatment of rheumatoid arthritis.
    Ralston SH; Willocks LJ; Shaw RW; Pitkeathly DA
    Br J Rheumatol; 1987 Dec; 26(6):472-3. PubMed ID: 2891393
    [No Abstract]   [Full Text] [Related]  

  • 34. Desensitization for sulfasalazine skin rash.
    Purdy BH; Philips DM; Summers RW
    Ann Intern Med; 1984 Apr; 100(4):512-4. PubMed ID: 6142671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The three week sulphasalazine syndrome.
    Brooks H; Taylor HG; Nichol FE
    Clin Rheumatol; 1992 Dec; 11(4):566-8. PubMed ID: 1362531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug rash with eosinophilia and systemic symptoms syndrome induced by sulfasalazine.
    Bahat G; Celik HG; Tufan F; Saka B
    Joint Bone Spine; 2010 Jan; 77(1):87-8. PubMed ID: 19854669
    [No Abstract]   [Full Text] [Related]  

  • 37. The long term effects of sulphasalazine in the treatment of rheumatoid arthritis and a comparative study with penicillamine.
    Farr M; Tunn E; Crockson AP; Bacon PA
    Clin Rheumatol; 1984 Dec; 3(4):473-81. PubMed ID: 6151882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulphasalazine in the treatment of rheumatoid arthritis.
    Pelísková Z; Vácha J; Trnavský K
    Z Rheumatol; 1985; 44(6):263-6. PubMed ID: 2869625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sulphasalazine. An alternative drug for second-line treatment of juvenile chronic arthritis.
    Varbanova BB; Dyankov ED
    Adv Exp Med Biol; 1999; 455():331-6. PubMed ID: 10599365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse interaction between intramuscular methylprednisolone and sulphasalazine in patients with early rheumatoid arthritis. A pilot study.
    Gough A; Sheeran T; Arthur V; Panayi G; Emery P
    Scand J Rheumatol; 1994; 23(1):46-8. PubMed ID: 7906428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.